95 related articles for article (PubMed ID: 2613276)
21. Reovirus transport--studies using lymphocytosis promoting factor.
Sugimoto M; Sharpe AH; Sato Y; Greene MI; Fields BN
Pathobiology; 1990; 58(4):185-92. PubMed ID: 2174674
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms of pertussis toxin inhibition of lymphocyte-HEV interactions. I. Analysis of lymphocyte homing receptor-mediated binding mechanisms.
Steen PD; Ashwood ER; Huang K; Daynes RA; Chung HT; Samlowski WE
Cell Immunol; 1990 Nov; 131(1):67-85. PubMed ID: 2225081
[TBL] [Abstract][Full Text] [Related]
23. Molecular mechanisms of lymphocyte extravasation. II. Studies of in vitro lymphocyte adherence to high endothelial venules.
Braaten BA; Spangrude GJ; Daynes RA
J Immunol; 1984 Jul; 133(1):117-22. PubMed ID: 6539352
[TBL] [Abstract][Full Text] [Related]
24. Pertussis toxin prevents the induction of peripheral T cell anergy and enhances the T cell response to an encephalitogenic peptide of myelin basic protein.
Kamradt T; Soloway PD; Perkins DL; Gefter ML
J Immunol; 1991 Nov; 147(10):3296-302. PubMed ID: 1719074
[TBL] [Abstract][Full Text] [Related]
25. Suppression of the cytotoxic T-lymphocyte response in mice by pertussis toxin.
Arora PK; Sekura RD; Hanna EE
Cell Immunol; 1987 Nov; 110(1):1-13. PubMed ID: 2960456
[TBL] [Abstract][Full Text] [Related]
26. Activation of pertussis toxin-sensitive CXCL12 (SDF-1) receptors mediates transendothelial migration of T lymphocytes across lymph node high endothelial cells.
Phillips R; Ager A
Eur J Immunol; 2002 Mar; 32(3):837-47. PubMed ID: 11870628
[TBL] [Abstract][Full Text] [Related]
27. Pertussis toxin effects on T lymphocytes are mediated through CD3 and not by pertussis toxin catalyzed modification of a G protein.
Gray LS; Huber KS; Gray MC; Hewlett EL; Engelhard VH
J Immunol; 1989 Mar; 142(5):1631-8. PubMed ID: 2521885
[TBL] [Abstract][Full Text] [Related]
28. Lymphocyte proliferation induced by pertussis toxin utilizes a pathway parallel to transforming growth factor-beta-sensitive growth.
Cronkhite RI
Int Arch Allergy Immunol; 1993; 102(2):141-3. PubMed ID: 8400894
[TBL] [Abstract][Full Text] [Related]
29. A quantitative analysis for the ADP-ribosylation activity of pertussis toxin: an enzymatic-HPLC coupled assay applicable to formulated whole cell and acellular pertussis vaccine products.
Cyr T; Menzies AJ; Calver J; Whitehouse LW
Biologicals; 2001 Jun; 29(2):81-95. PubMed ID: 11580213
[TBL] [Abstract][Full Text] [Related]
30. Cap formation in a B-lymphocyte cell line is inhibited by pertussis toxin and phorbol ester.
Grewal IS; Olson CV; Scott SJ; Lad PM
Immunology; 1987 Jun; 61(2):131-5. PubMed ID: 3496269
[TBL] [Abstract][Full Text] [Related]
31. Enhancement of interleukin-4 production by pertussis toxin.
Mu HH; Sewell WA
Infect Immun; 1993 Jul; 61(7):2834-40. PubMed ID: 8514386
[TBL] [Abstract][Full Text] [Related]
32. A pertussis toxin-sensitive process controls thymocyte emigration.
Chaffin KE; Perlmutter RM
Eur J Immunol; 1991 Oct; 21(10):2565-73. PubMed ID: 1655469
[TBL] [Abstract][Full Text] [Related]
33. FK506 and pertussis toxin distinguish growth-induced locomotor activation from attractant-stimulated locomotion in human blood lymphocytes.
Wilkinson PC; Watson EA
Immunology; 1990 Nov; 71(3):417-22. PubMed ID: 1702750
[TBL] [Abstract][Full Text] [Related]
34. Reversal of the CD4(+)/CD8(+) T-cell ratio in lymph node cells upon in vitro mitogenic stimulation by highly purified, water-soluble S3-S4 dimer of pertussis toxin.
Latif R; Kerlero de Rosbo N; Amarant T; Rappuoli R; Sappler G; Ben-Nun A
Infect Immun; 2001 May; 69(5):3073-81. PubMed ID: 11292726
[TBL] [Abstract][Full Text] [Related]
35. Protective immunogenicity of synthetic peptides selected from the amino acid sequence of Bordetella pertussis toxin subunit S1.
Askelöf P; Rodmalm K; Wrangsell G; Larsson U; Svenson SB; Cowell JL; Undén A; Bartfai T
Dev Biol Stand; 1991; 73():111-20. PubMed ID: 1778305
[TBL] [Abstract][Full Text] [Related]
36. The in vitro effects of Bordetella pertussis lymphocytosis-promoting factor on murine lymphocytes. I. Proliferative response.
Kong AS; Morse SI
J Exp Med; 1977 Jan; 145(1):151-62. PubMed ID: 187715
[TBL] [Abstract][Full Text] [Related]
37. Cyclic AMP levels in lung and spleen tissue of mice treated with pertussis toxin.
Torre D; Pugliese A; Quadrelli C; Speranza F; Sampietro C
Microbiologica; 1989 Jan; 12(1):29-33. PubMed ID: 2541317
[TBL] [Abstract][Full Text] [Related]
38. Distribution of labeled lymph node cells in mice during the lymphocytosis induced by Bordetella pertussis.
Taub RN; Rosett W; Adler A; Morse SI
J Exp Med; 1972 Dec; 136(6):1581-93. PubMed ID: 4345107
[TBL] [Abstract][Full Text] [Related]
39. Pertussis toxin treatment in vivo reduces surface expression of the adhesion integrin leukocyte function antigen-1 (LFA-1).
Schenkel AR; Pauza CD
Cell Adhes Commun; 1999; 7(3):183-93. PubMed ID: 10626903
[TBL] [Abstract][Full Text] [Related]
40. Effect of Bordetella pertussis leukocytosis (lymphocytosis)-promoting factor (LPF) on the physical lymphoepithelial-cell association studied with the use of an in vitro model of mouse thymus.
Sugimoto M; Nakanishi Y; Otokawa M; Uchida N; Yasuda T; Sato H; Sato Y
J Immunol; 1983 Jun; 130(6):2767-74. PubMed ID: 6682875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
